Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| Agreement #184714 | Other Grant/Funding Number | Oregon Health Authority |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Clatsop Behavioral Healthcare | UNKNOWN |
| Oregon Health Authority | OTHER |
| Clatsop County Corrections | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
People leaving jail face a very high risk of overdose, especially in the first few weeks after release. Staying on medication for opioid use disorder (MOUD) can greatly reduce this risk, but many people stop treatment during this transition. This study is testing whether a program that offers rewards, called contingency management (CM), can help people stay on MOUD after they return to the community.
In this study, people who are taking MOUD in jail can choose to participate. While still incarcerated, they complete one visit where they may receive a small incentive, such as commissary credit or snacks, for enrolling in the CM program. After they leave jail, participants can earn gift cards when they attend their MOUD appointments and counseling sessions.
Participants may take part in the study for up to three months after release. During this time, they can earn up to $600 in incentives based on their treatment engagement. Researchers will also ask participants to complete a baseline survey and a survey at 3 months. We will also review medical records to confirm whether they continued their MOUD.
The researchers want to learn whether this adapted contingency management program is feasible, acceptable to participants, and helpful for supporting treatment engagement after release from jail. The findings will help determine whether this approach should be tested in a larger study to reduce overdose risk and improve health during the post-release period.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| RISE-CM Intervention | Other | All participants are enrolled in the intervention arm. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Reentry Incentives and Support for Engagement with Contingency Management (RISE-CM) Intervention | Other | Participants receive gift card rewards for attending MOUD appointments and counseling appointments after release from incarceration. |
| Measure | Description | Time Frame |
|---|---|---|
| Number of patients receiving medication for opioid use disorder | We will assess patient reported receipt of medication for opioid use disorder and also use chart review to determine whether patients are receiving medications and three different time points. | 1, 2, and 3 months |
| Measure | Description | Time Frame |
|---|---|---|
| Number of contingency management sessions attended | Number of contingency management sessions attended per participant | 3 months |
| Total contingency management rewards earned | Total dollar amount of contingency management rewards earned by participant throughout the intervention |
Not provided
Inclusion Criteria:
Exclusion Criteria
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Carol DeFrancesco Senior Research Associate | Contact | 5033105036 | defrance@ohsu.edu | |
| Linda Peng, MD | Contact | 5034941801 | pengli@ohsu.edu |
| Name | Affiliation | Role |
|---|---|---|
| Linda Peng, MD | Oregon Health and Science University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Clatsop County Corrections | Warrenton | Oregon | 97146 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D009293 | Opioid-Related Disorders |
| ID | Term |
|---|---|
| D000079524 | Narcotic-Related Disorders |
| D019966 | Substance-Related Disorders |
| D064419 | Chemically-Induced Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided
| ID | Term |
|---|---|
| D010166 | Palliative Care |
| D008722 | Methods |
| ID | Term |
|---|---|
| D005791 | Patient Care |
| D013812 | Therapeutics |
| D006296 | Health Services |
| D005159 | Health Care Facilities Workforce and Services |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 3 months |
| Addiction Severity | Participant reported addiction severity using the validated Brief Addiction Monitor, a 17-item, multidimensional progress monitoring tool designed to support the provision of measurement-based care to patients commencing and matriculating through treatment for substance use disorders (SUD). The BAM items assess: (1) Risk for relapse or worsening severity of SUD (Range 0-180 with higher scores indicating higher risk), (2) Protective behaviors that support recovery and resistance to relapse (Range 0-180 with higher score indicating higher protective factors), and (3) Use of alcohol and other substances (Range 0-90 with higher score indicating higher substance use). | Baseline and 3 months |
| Recovery Capital | Participant reported survey on recovery capital using the validated "Brief Assessment of Recovery Capital (BARC-10)" survey. Score range 10-60 with higher scores indicating higher recovery capital. | Baseline and 3 months |
| D008919 | Investigative Techniques |